— Know what they know.
Not Investment Advice
Also trades as: 0HIY.L (LSE) · $vol 0M

ATRA NASDAQ

Atara Biotherapeutics, Inc.
1W: -9.4% 1M: -0.8% 3M: +3.0% YTD: -53.3% 1Y: -42.7% 3Y: -75.8% 5Y: -97.8%
$8.30
-0.05 (-0.60%)
 
Weekly Expected Move ±10.1%
$7 $8 $9 $9 $10
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 36 · $83.3M mcap · 7M float · 0.796% daily turnover · Short 36% of daily vol
Credit Risk of going bust: higher than 91% of companies Debt: 10.6% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the riskiest tenth, about 1 in 20 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.25 (down 97%), Atara Biotherapeutics, Inc. would be worth roughly what it owes.
Total debt $9.9M against a stock market value of $83.3M.
Distance to default 1.49 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $4.9M (short-term plus half of long-term), stock volatility 142.0%; Altman Z'' -317.91. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
37.0 / 100
NoneWeakNarrowWide
Primary source: Intangible Assets  ·  ROIC: 30.3%
Cost Advantage
39
Intangibles
48
Switching Cost
29
Network Effect
39
Scale
27
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ATRA has No discernible competitive edge (37.0/100). The business operates without significant structural advantages. The primary source of advantage is Intangible Assets. ROIC of 30.3% confirms the company is generating returns well above its cost of capital — a hallmark of durable competitive advantages.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$15
Avg Target
$15
High
Based on 3 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 4Hold: 7Sell: 2Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$14.67
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-08 Canaccord Genuity — $25 $13 -12 +30.9% $9.93
2026-01-13 New Street — Initiated $6 — +35.7% $4.42
2025-12-19 Canaccord Genuity — Initiated $25 — +45.1% $17.23
2024-11-13 Stifel Nicolaus Benjamin Burnett Initiated $10 — +31.9% $7.58
2024-08-16 Mizuho Securities Salim Syed Initiated $18 — +163.5% $6.83
2022-08-09 Goldman Sachs — $4 $3 -1 -22.5% $3.87
2022-05-24 Goldman Sachs — Initiated $4 — -17.5% $4.85

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C
Oct 27, 2026
DCF
1
ROE
5
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ATRA receives an overall rating of C. Strongest factors: ROE (5/5). Areas of concern: DCF (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-05-12 C+ C
2026-01-03 C C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 7 Grade D
Profitability
20
Balance Sheet
36
Earnings Quality
41
Growth
12
Value
15
Momentum
20
Safety
0
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ATRA scores highest in Earnings Quality (41/100) and lowest in Safety (0/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-134.95
Distress Zone
Piotroski F-Score
2/9
✗ ✗ ✗ ✗ ✓ ✓ ✗ ✗ ✗
Beneish M-Score
-4.95
Unlikely Manipulator
Ohlson O-Score
9.42
Bankruptcy prob: 100.0%
High Risk
Credit Rating
B-
Score: 20.0/100
Trend: Stable
Earnings Quality
—
OCF/NI: 1.31x
Accruals: 18.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ATRA scores -134.95, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ATRA scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ATRA's score of -4.95 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ATRA's implied 100.0% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ATRA receives an estimated rating of B- (score: 20.0/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-7.03x
PEG
0.05x
P/S
13.45x
P/B
-3.37x
P/FCF
-7.88x
P/OCF
—
EV/EBITDA
-12.59x
EV/Revenue
27.86x
EV/EBIT
-12.47x
EV/FCF
-7.88x
Earnings Yield
-9.67%
FCF Yield
-12.69%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ATRA currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.002
NI / EBT
×
Interest Burden
1.204
EBT / EBIT
×
EBIT Margin
-2.234
EBIT / Rev
×
Asset Turnover
0.214
Rev / Assets
×
Equity Multiplier
-0.804
Assets / Equity
=
ROE
46.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ATRA's ROE of 46.3% is driven by Asset Turnover (0.214), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$8.30
Median 1Y
$2.31
5th Pctile
$0.29
95th Pctile
$18.13
Ann. Volatility
123.3%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Pascal Touchon, D.V.M.
Former President and Chief Executive Officer
$503,633 $716,800 $1,722,332
AnhCo Nguyen, Ph.D.
President and Chief Executive Officer
$585,769 $781,650 $1,573,716
Eric Hyllengren EVP,
er EVP, Chief Financial Officer and Chief Operating Officer
$489,751 $266,000 $926,137
Amar Murugan EVP,
er EVP, Chief Legal Officer
$447,654 $266,000 $878,428
Jill Henrich EVP,
er EVP, Chief Regulatory Officer
$503,846 $252,000 $812,547

CEO Pay Ratio

1:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $1,722,332
Avg Employee Cost (SGA/emp): $1,875,214
Employees: 14

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
14
-90.8% YoY
Revenue / Employee
$8,626,571
Rev: $120,772,000
Profit / Employee
$2,334,857
NI: $32,688,000
SGA / Employee
$1,875,214
Avg labor cost proxy
R&D / Employee
$2,674,643
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE -98.8% -91.7% -1.1% -84.1% -99.4% -1.1% -1.5% -2.3% -4.3% -20.1% 14.0% 3.5% 1.9% 86.9% 20.4% -7.9% -36.8% -48.1% 20.5% 46.3% 46.33%
ROA -76.7% -64.4% -75.5% -55.5% -60.4% -54.1% -61.5% -89.2% -1.0% -1.0% -99.8% -99.6% -80.3% -62.2% -13.8% 7.5% 27.1% 50.5% -23.1% -57.6% -57.62%
ROIC 11.5% 4.3% 4.6% 24.0% 13.7% 5.0% 2.5% 3.0% 2.5% 2.3% 2.0% 1.5% 1.1% 68.7% 76.2% -20.4% 3.2% 6.2% 13.9% 30.3% 30.32%
ROCE -90.3% -94.0% -1.2% -66.9% -83.4% -75.0% -89.0% -1.7% -2.6% -11.6% 14.8% 5.7% 9.7% 3.2% -79.2% 44.5% 2.3% 6.9% -40.6% -97.6% -97.59%
Gross Margin 1.0% -9.5% 1.0% 1.0% 1.0% -270.4% 82.4% -2.0% -22.3% 25.7% 92.7% 83.8% 81.1% 79.3% 79.2% 96.8% 96.7% 93.5% 76.0% 69.7% 69.68%
Operating Margin -15.8% -12.4% -12.1% -62.3% -19.0% -341.8% -61.2% -74.6% -32.6% -12.5% -1.1% -63.7% -54.1% -37.3% 39.5% 18.2% -1.0% -1.6% -6.5% -7.5% -7.49%
Net Margin -15.8% -12.4% -12.0% 35.8% -18.9% -337.4% -61.0% -74.3% -32.6% -14.2% -1.2% -66.5% -54.5% -38.8% 38.7% 13.6% -1.2% -2.1% -8.0% -7.7% -7.67%
EBITDA Margin -15.4% -12.1% -11.8% 38.8% -18.5% -309.1% -58.9% -71.6% -31.4% -13.7% -1.1% -57.5% -48.6% -32.3% 41.6% 20.5% -96.4% -1.5% -6.4% -7.3% -7.35%
FCF Margin -15.6% -11.4% -10.4% -3.5% -3.6% -4.3% -3.9% -31.2% -44.2% -22.7% -5.3% -2.3% -94.4% -53.5% -33.7% -33.9% -45.9% -42.2% -1.1% -3.5% -3.53%
OCF Margin -14.9% -10.8% -9.9% -3.4% -3.5% -4.3% -3.9% -31.1% -43.9% -22.5% -5.3% -2.3% -94.2% -53.3% -33.7% -33.9% -45.9% -42.2% -1.1% -3.5% -3.53%
ROA 3Y Avg snapshot only -72.68%
ROIC Economic snapshot only 41.18%
Cash ROA snapshot only -1.04%
NOPAT Margin snapshot only -1.81%
Pretax Margin snapshot only -2.69%
R&D / Revenue snapshot only 67.74%
SGA / Revenue snapshot only 2.53%
SBC / Revenue snapshot only 62.72%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio -5.11 -4.51 -2.67 -3.20 -1.57 -1.48 -1.40 -0.56 -0.54 -0.20 -0.42 -0.29 -0.46 -1.67 -4.12 16.40 8.31 7.04 -7.04 -10.34 -7.034
P/S Ratio 130.98 75.47 38.82 11.05 5.46 5.32 5.25 24.66 34.67 6.47 2.81 0.84 0.60 1.10 0.32 0.50 1.28 1.90 2.88 27.86 13.451
P/B Ratio 5.40 5.49 4.17 3.08 2.07 2.67 4.64 22.70 -3.10 -0.56 -0.99 -0.47 -0.67 -1.46 -1.17 -2.71 -5.31 -5.98 -1.79 -4.66 -3.373
P/FCF -8.42 -6.64 -3.74 -3.15 -1.52 -1.23 -1.33 -0.79 -0.78 -0.29 -0.53 -0.37 -0.64 -2.06 -0.96 -1.48 -2.78 -4.52 -2.57 -7.88 -7.882
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -4.21 -3.60 -1.91 -2.19 -0.76 -0.77 -0.74 -0.28 -0.42 -0.23 -0.48 -0.41 -0.48 -1.90 -18.40 6.31 7.85 7.10 -12.47 -12.59 -12.591
EV/Revenue 104.97 58.62 27.03 7.33 2.58 2.63 2.63 11.70 25.73 7.19 3.10 1.12 0.58 1.11 0.53 0.48 1.57 2.27 2.95 27.86 27.863
EV/EBIT -4.09 -3.50 -1.86 -2.12 -0.74 -0.75 -0.72 -0.27 -0.42 -0.23 -0.47 -0.40 -0.46 -1.78 -9.43 9.08 8.76 7.52 -11.72 -12.47 -12.475
EV/FCF -6.74 -5.16 -2.60 -2.09 -0.72 -0.61 -0.67 -0.37 -0.58 -0.32 -0.58 -0.49 -0.62 -2.08 -1.57 -1.41 -3.43 -5.39 -2.64 -7.88 -7.882
Earnings Yield -19.6% -22.2% -37.4% -31.2% -63.8% -67.5% -71.3% -1.8% -1.8% -5.0% -2.4% -3.5% -2.2% -60.0% -24.3% 6.1% 12.0% 14.2% -14.2% -9.7% -9.67%
FCF Yield -11.9% -15.1% -26.8% -31.8% -65.7% -81.1% -75.1% -1.3% -1.3% -3.5% -1.9% -2.7% -1.6% -48.5% -1.0% -67.4% -35.9% -22.1% -38.8% -12.7% -12.69%
PEG Ratio snapshot only 0.047
EV/Gross Profit snapshot only 30.492
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 4.29 3.64 3.10 5.28 3.92 3.74 3.30 2.31 1.50 0.72 0.59 0.42 0.59 0.48 0.57 1.70 1.02 0.82 2.16 1.98 1.976
Quick Ratio 4.29 3.64 3.10 5.28 3.92 3.72 3.22 2.21 1.42 0.65 0.50 0.29 0.50 0.40 0.57 1.70 1.02 0.82 2.16 1.98 1.976
Debt/Equity 0.08 0.10 0.08 0.25 0.33 0.57 0.85 8.68 -1.22 -0.58 -0.57 -0.48 -0.72 -0.45 -1.00 -0.50 -1.60 -1.37 -0.27 -0.27 -0.267
Net Debt/Equity -1.07 -1.23 -1.27 -1.04 -1.09 -1.35 -2.32 -11.93 — — — — — — — — — — — — —
Debt/Assets 0.05 0.06 0.04 0.15 0.17 0.19 0.18 0.26 0.33 0.35 0.34 0.45 0.46 0.40 0.89 0.48 1.94 2.61 0.50 0.47 0.470
Debt/EBITDA -0.08 -0.09 -0.05 -0.27 -0.25 -0.33 -0.27 -0.22 -0.22 -0.22 -0.25 -0.31 -0.53 -0.58 -9.58 1.23 1.92 1.37 -1.84 -0.72 -0.721
Net Debt/EBITDA 1.04 1.04 0.83 1.11 0.85 0.79 0.74 0.30 0.15 -0.02 -0.04 -0.10 0.02 -0.02 -7.17 -0.33 1.47 1.15 -0.32 -0.00 -0.000
Interest Coverage -3648.42 -3782.91 -87579.50 -1862.56 -964.32 -871.25 -131.20 -104.57 -68.42 -51.24 -44.69 -35.31 -26.89 -17.51 -2.50 2.38 6.98 9.63 -1.62 -4.90 -4.899
Equity Multiplier 1.45 1.67 1.77 1.69 1.97 2.97 4.65 33.06 -3.71 -1.67 -1.68 -1.06 -1.58 -1.12 -1.13 -1.05 -0.82 -0.53 -0.54 -0.57 -0.568
Cash Ratio snapshot only 1.442
Debt Service Coverage snapshot only -4.854
Cash to Debt snapshot only 0.999
FCF to Debt snapshot only -2.216
Defensive Interval snapshot only 187.3 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.03 0.04 0.05 0.16 0.17 0.15 0.16 0.02 0.02 0.03 0.15 0.34 0.61 0.94 1.76 2.45 1.76 1.87 0.56 0.21 0.214
Inventory Turnover — — — — — 75.63 22.54 16.05 19.94 1.57 0.99 0.93 1.69 2.06 4.91 3.78 3.99 3.98 — — —
Receivables Turnover — 18.19 4.69 225.47 569.48 3.09 107.95 12.00 22.05 0.23 1.92 42.60 134.10 7.25 8.93 155.79 93.55 88.32 5.21 38.96 38.956
Payables Turnover 12.43 17.29 10.08 6.31 5.69 4.95 7.08 7.45 7.38 1.68 2.69 2.64 4.01 5.22 18.62 10.09 22.65 9.44 0.89 0.41 0.413
DSO 0 20 78 2 1 118 3 30 17 1582 191 9 3 50 41 2 4 4 70 9 9.4 days
DIO 0 0 0 0 0 5 16 23 18 232 367 392 216 177 74 97 91 92 0 0 0.0 days
DPO 29 21 36 58 64 74 52 49 49 217 136 138 91 70 20 36 16 39 411 884 883.8 days
Cash Conversion Cycle -29 -1 42 -56 -64 49 -32 4 -15 1597 422 262 128 157 96 63 79 57 -341 -874 -874.4 days
Fixed Asset Turnover snapshot only 0.920
Cash Velocity snapshot only 0.627
Capital Intensity snapshot only 3.394
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue — — 5.8% 8.7% 4.5% 2.1% 1.4% -90.4% -93.6% -86.5% -39.6% 8.1% 21.1% 14.0% 4.8% 2.0% 51.3% -6.3% -88.4% -96.7% -96.72%
Net Income -8.0% -10.9% -12.4% 22.1% 24.7% 32.9% 38.6% -23.0% -17.5% -20.9% -8.4% 40.6% 54.1% 69.1% 93.3% 1.0% 1.2% 1.4% 39.5% -3.9% -3.88%
EPS 6.3% 2.9% -2.0% 29.5% 31.2% 36.6% 40.5% -19.2% -13.1% -15.4% 19.8% 59.3% 73.8% 87.5% 96.5% 1.0% 1.1% 1.3% 53.4% -3.4% -3.36%
FCF 17.7% -24.7% -35.5% -32.9% -27.8% -18.8% 9.6% 15.0% 21.1% 29.3% 18.2% 33.5% 52.7% 64.5% 63.6% 55.1% 26.4% 26.1% 61.6% 65.8% 65.79%
EBITDA -6.7% -10.4% -12.7% 22.3% 24.7% 34.4% 40.6% -21.5% -15.1% -22.4% -9.8% 41.4% 55.4% 71.5% 97.4% 1.1% 1.2% 1.5% 4.6% -2.0% -1.96%
Op. Income -7.1% -10.2% -12.1% 6.3% 9.2% 17.6% 23.7% -2.7% 2.3% 4.0% 15.6% 43.8% 57.3% 69.0% 94.1% 1.0% 1.2% 1.4% 53.1% -2.8% -2.77%
OCF Growth snapshot only 65.74%
Asset Growth snapshot only -43.03%
Debt Growth snapshot only -44.09%
Shares Change snapshot only 22.12%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y — — — — — — — — — — 1.1% 1.0% 98.8% 85.1% 1.0% 38.0% 28.9% 23.9% -26.2% -3.4% -3.36%
Revenue 5Y — — — — — — — — — — — — — — — — — — 45.5% -3.6% -3.55%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — — — — — — — — — — — — — 2.0% — — —
Gross Profit 5Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 0.5% 6.1% 7.0% 16.7% 0.3% 3.2% 0.3% -16.8% -22.5% -34.5% -32.2% -36.4% -31.8% -38.5% -46.1% -56.1% -56.6% -62.3% -59.5% -56.0% -55.98%
Assets 5Y 9.6% 12.1% 10.4% 12.3% 9.9% 11.6% -8.6% -12.9% -15.7% -15.8% -12.6% -15.6% -17.1% -20.5% -27.0% -38.8% -40.5% -49.0% -48.1% -46.0% -45.97%
Equity 3Y -8.4% -6.2% -7.6% 3.5% -16.2% -24.2% -36.4% -73.1% — — — — — — — — — — — — —
Book Value 3Y -28.0% -27.1% -28.7% -20.4% -32.0% -37.6% -46.7% -76.7% — — — — — — — — — — — — —
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.41 0.41 0.50 0.48 0.52 0.60 0.67 0.19 0.18 0.24 0.66 0.34 0.44 0.50 0.61 0.55 0.64 0.64 0.16 0.14 0.139
Earnings Stability 0.04 0.09 0.18 0.27 0.30 0.49 0.60 0.61 0.56 0.71 0.74 0.63 0.48 0.52 0.60 0.71 0.75 0.79 0.84 0.81 0.814
Margin Stability — — — — — — 0.00 0.00 0.11 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.50 0.50 1.00 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 1.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.97 0.96 0.95 0.91 0.90 0.87 0.85 0.91 0.93 0.92 0.97 0.84 0.50 0.50 0.50 0.20 0.20 0.20 0.84 0.20 0.200
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend 3.96 2.90 2.02 0.76 -0.36 -0.86 -2.14 -39.90 — — — — — — — — — — — — —
Gross Margin Trend — — — — — — 28.48 4.49 -8.63 4.64 3.28 4.95 7.62 0.83 0.48 4.51 7.13 0.42 0.21 0.11 0.107
FCF Margin Trend — — — — — — 27.27 -16.68 -34.60 -14.81 1.83 15.08 22.94 12.95 4.30 16.41 22.10 11.17 1.72 -2.22 -2.223
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — 8.1% 37.1% 1.0% — — —
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 0.58 0.65 0.68 0.98 1.00 1.18 1.04 0.70 0.69 0.70 0.79 0.78 0.71 0.80 4.30 -11.03 -2.98 -1.56 2.73 1.31 1.312
FCF/OCF 1.05 1.05 1.05 1.04 1.03 1.02 1.01 1.01 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 1.312
CapEx/Revenue 68.1% 52.0% 45.6% 14.4% 9.3% 6.6% 3.5% 15.5% 26.8% 14.3% 2.7% 0.8% 0.2% 0.2% 0.1% 0.0% 0.1% 0.0% 0.0% 0.0% 0.00%
CapEx/Depreciation snapshot only 0.000
Accruals Ratio -0.32 -0.23 -0.24 -0.01 0.00 0.10 0.03 -0.27 -0.33 -0.31 -0.21 -0.21 -0.23 -0.12 0.45 0.90 1.08 1.29 0.40 0.18 0.180
Sloan Accruals snapshot only -0.126
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — 0.0% 0.0% 0.0% — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — 0.0% 0.0% 0.0% — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -13.4% -6.4% -12.5% -14.7% -18.2% -15.5% -10.8% -19.3% -20.7% -3.9% -26.5% -20.9% -1.0% -42.1% -55.2% -53.2% -0.4% -0.4% -6.0% -5.1% -5.10%
Total Shareholder Return -13.4% -6.4% -12.5% -14.7% -18.2% -15.5% -10.8% -19.3% -20.7% -3.9% -26.5% -20.9% -1.0% -42.1% -55.2% -53.2% -0.4% -0.4% -6.0% -5.1% -5.10%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.00 1.00 1.00 1.00 1.002
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.00 1.02 1.03 1.03 1.03 1.02 1.02 1.03 1.04 1.06 1.40 0.58 0.86 0.90 1.62 1.20 1.204
EBIT Margin -25.67 -16.74 -14.53 -3.45 -3.48 -3.51 -3.62 -43.23 -61.90 -31.59 -6.57 -2.82 -1.28 -0.63 -0.06 0.05 0.18 0.30 -0.25 -2.23 -2.234
Asset Turnover 0.03 0.04 0.05 0.16 0.17 0.15 0.16 0.02 0.02 0.03 0.15 0.34 0.61 0.94 1.76 2.45 1.76 1.87 0.56 0.21 0.214
Equity Multiplier 1.29 1.42 1.49 1.52 1.65 2.08 2.42 2.58 4.09 19.77 -14.01 -3.52 -2.34 -1.40 -1.48 -1.06 -1.36 -0.95 -0.89 -0.80 -0.804
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $-87.63 $-87.30 $-86.85 $-60.78 $-60.31 $-55.32 $-51.69 $-72.44 $-68.20 $-63.84 $-41.45 $-29.47 $-17.84 $-7.99 $-1.44 $0.47 $1.73 $2.57 $-0.67 $-1.11 $-1.11
Book Value/Share $82.84 $71.76 $55.67 $63.19 $45.67 $30.68 $15.62 $1.77 $-11.94 $-22.94 $-17.48 $-18.05 $-12.13 $-9.10 $-5.08 $-2.85 $-2.70 $-3.03 $-2.65 $-2.46 $-2.46
Tangible Book/Share $82.84 $71.76 $55.67 $63.19 $45.67 $30.68 $15.62 $1.77 $-11.94 $-22.94 $-17.48 $-18.05 $-12.13 $-9.10 $-5.08 $-2.85 $-2.70 $-3.03 $-2.65 $-2.46 $-2.46
Revenue/Share $3.42 $5.22 $5.98 $17.62 $17.31 $15.40 $13.82 $1.63 $1.07 $1.98 $6.17 $10.16 $13.45 $12.06 $18.41 $15.33 $11.20 $9.50 $1.64 $0.41 $0.41
FCF/Share $-53.17 $-59.31 $-62.13 $-61.87 $-62.11 $-66.54 $-54.42 $-50.96 $-47.15 $-44.90 $-32.92 $-23.20 $-12.70 $-6.45 $-6.21 $-5.20 $-5.15 $-4.01 $-1.84 $-1.46 $-1.46
OCF/Share $-50.85 $-56.60 $-59.41 $-59.33 $-60.49 $-65.53 $-53.94 $-50.70 $-46.86 $-44.61 $-32.75 $-23.12 $-12.68 $-6.43 $-6.20 $-5.19 $-5.14 $-4.01 $-1.84 $-1.46 $-1.46
Cash/Share $95.42 $95.24 $74.91 $81.31 $64.78 $58.83 $49.39 $36.55 $24.06 $11.96 $8.22 $5.75 $9.00 $3.98 $1.28 $1.81 $1.01 $0.67 $0.59 $0.66 $0.66
EBITDA/Share $-85.18 $-84.99 $-84.80 $-58.89 $-58.59 $-52.67 $-48.83 $-69.37 $-64.91 $-61.50 $-39.65 $-27.82 $-16.50 $-7.09 $-0.53 $1.16 $2.25 $3.04 $-0.39 $-0.91 $-0.91
Debt/Share $6.56 $7.26 $4.33 $15.71 $14.91 $17.37 $13.21 $15.39 $14.52 $13.38 $10.00 $8.58 $8.73 $4.10 $5.07 $1.44 $4.32 $4.15 $0.72 $0.66 $0.66
Net Debt/Share $-88.85 $-87.98 $-70.58 $-65.60 $-49.87 $-41.46 $-36.19 $-21.15 $-9.54 $1.42 $1.78 $2.83 $-0.27 $0.12 $3.80 $-0.38 $3.31 $3.48 $0.12 $0.00 $0.00
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -134.946
Altman Z-Prime snapshot only -314.118
Piotroski F-Score 2 2 3 5 2 3 3 1 1 2 2 4 4 4 2 5 5 5 3 2 2
Beneish M-Score — — 1.63 0.47 -1.23 1275.53 -1.58 26.26 -7.84 -545.83 17.79 19.06 10.88 1.48 2.92 4.22 23.77 28.34 -11.21 -4.95 -4.953
Ohlson O-Score snapshot only 9.415
Net-Net WC snapshot only $-2.96
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only B-
Credit Score 39.21 30.59 31.75 30.78 31.31 29.82 29.70 21.45 20.00 15.25 15.55 12.76 12.88 12.92 15.08 20.00 20.00 20.00 20.00 20.00 20.000
Credit Grade snapshot only 16
Credit Trend snapshot only 0.000
Implied Spread (bps) snapshot only 900.000
Industry Credit Rank snapshot only 12
Sector Credit Rank snapshot only 13

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms